The Brink's Company BCO
Set alert
107.37 USD +0.02 +0.02%
As of Nov 3, 10:01 AM ET
107.02 Day range 107.74
91.05 52-week range 136.37
- YTD
- -8.02%
- 1 year
- -2.91%
- Open
- 107.62
- Prev close
- 107.35
- Mkt cap
- 4.41B
- Vol
- 8.38K
- Avg vol
- 454.30K
- EPS
- 4.31
- P/E
- 24.83
- Div yield
- 1.00%
More statistics
- Low
- 107.02
- High
- 107.74
- Forward P/E
- 10.67
- Beta
- 0.93
- Short ratio
- 12.12
- Inst. own
- 114.04%
- Dividend
- 1.02
- Ex-div date
- Nov 1, 2026
- Earnings
- Nov 4, 2026
- 50-d avg
- 106.44
- 200-d avg
- 110.37
- 1y target
- 145.00
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 145.00 +35.0% upside
Now 107.37
- Target (low)
- 134.00
- Target (mean)
- 145.00
- Target (high)
- 163.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy0
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
- 2 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 2.41 | 2.40 – 2.42 | 2.08 | +15.7% | 1.39B | +3.9% | 3 |
| Next quarter | 2.74 | 2.70 – 2.78 | 2.54 | +8.0% | 1.41B | +2.2% | 3 |
| Current year | 9.08 | 9.03 – 9.13 | 8.05 | +12.8% | 5.56B | +5.7% | 3 |
| Next year | 10.06 | 9.89 – 10.25 | 9.08 | +10.8% | 5.75B | +3.4% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 2, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Feb 10, 2026 | Truist Securities | Maintained | Buy | Buy |
| Nov 7, 2024 | Truist Securities | Maintained | Buy | Buy |
| Sep 20, 2024 | Truist Securities | Maintained | Buy | Buy |
| May 21, 2024 | William Blair | Initiated | — | Outperform |
| Mar 1, 2024 | Goldman Sachs | Maintained | Buy | Buy |
| Feb 28, 2024 | Truist Securities | Maintained | Buy | Buy |
| Aug 10, 2023 | Goldman Sachs | Maintained | Buy | Buy |
| Mar 24, 2023 | Truist Securities | Maintained | — | Buy |
| May 7, 2020 | Imperial Capital | Maintained | — | Outperform |
| Apr 20, 2020 | SunTrust Robinson Humphrey | Maintained | — | Buy |
| Nov 20, 2019 | Goldman Sachs | Initiated | — | Buy |
| Sep 4, 2019 | Buckingham Research | Maintained | — | Neutral |
| Jul 25, 2019 | Imperial Capital | Maintained | — | Outperform |
| Jun 1, 2018 | Buckingham Research | Maintained | Buy | Buy |
| Mar 27, 2018 | Buckingham Research | Initiated | — | Buy |
| Aug 9, 2017 | Imperial Capital | Upgrade | In-Line | Outperform |
| Feb 28, 2017 | SunTrust Robinson Humphrey | Initiated | — | Buy |
| Oct 28, 2016 | Imperial Capital | Downgrade | Outperform | In-Line |
| Sep 16, 2016 | Macquarie | Maintained | — | Neutral |
| Aug 3, 2016 | Imperial Capital | Upgrade | In-Line | Outperform |
| May 6, 2015 | Imperial Capital | Downgrade | Outperform | In-Line |
| May 6, 2015 | Gabelli & Co. | Upgrade | Hold | Buy |
| Apr 23, 2015 | Macquarie | Downgrade | Outperform | Neutral |
| Mar 24, 2015 | Standpoint Research | Downgrade | Buy | Hold |
| Mar 19, 2015 | Macquarie | Initiated | — | Outperform |
| Dec 5, 2014 | Standpoint Research | Initiated | — | Buy |
| Nov 5, 2014 | Imperial Capital | Downgrade | Outperform | In-Line |
| Apr 16, 2014 | Imperial Capital | Downgrade | Outperform | In-Line |
| Jan 6, 2014 | Imperial Capital | Maintained | — | Outperform |